Enovix Quarterly Balance Sheets Chart
Quarterly
|
Annual
Enovix Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-29 | 2025-03-30 | 2024-12-29 | 2024-09-29 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-10-01 | 2023-07-02 | 2023-04-02 | 2023-01-01 | 2022-10-02 | 2022-07-03 | 2022-04-03 | 2022-01-02 | 2021-10-03 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||
| current assets: | ||||||||||||||||||
| cash and cash equivalents | 135,978,000 | 189,874,000 | 272,869,000 | 200,912,000 | 235,103,000 | 222,150,000 | 233,121,000 | 270,817,000 | 343,152,000 | 293,751,000 | 322,851,000 | 349,007,000 | 384,730,000 | 408,178,000 | 385,293,000 | 338,746,000 | ||
| short-term investments | 67,434,000 | 58,281,000 | 14,826,000 | 40,243,000 | 73,694,000 | 100,522,000 | 66,092,000 | |||||||||||
| accounts receivable | 4,244,000 | 2,897,000 | 4,566,000 | 1,911,000 | 1,665,000 | 1,728,000 | 909,000 | 1,000 | 42,000 | 21,000 | 170,000 | 6,000 | 102,000 | |||||
| notes receivable | 1,110,000 | 1,255,000 | 4,000 | 3,000 | 144,000 | 1,514,000 | ||||||||||||
| inventory | 13,385,000 | 10,483,000 | 7,664,000 | 9,564,000 | 9,508,000 | 6,536,000 | 8,737,000 | 215,000 | 796,000 | 815,000 | 634,000 | 452,000 | 669,000 | |||||
| prepaid expenses and other current assets | 6,189,000 | 7,382,000 | 9,903,000 | 11,598,000 | 8,844,000 | 7,207,000 | 5,202,000 | 4,182,000 | 2,932,000 | 5,857,000 | 5,193,000 | 4,507,000 | 2,026,000 | 2,824,000 | 8,274,000 | 3,771,000 | ||
| total current assets | 228,340,000 | 270,172,000 | 295,006,000 | 223,985,000 | 269,949,000 | 278,008,000 | 323,177,000 | 375,737,000 | 413,814,000 | 301,244,000 | 329,648,000 | 355,511,000 | 388,867,000 | 415,549,000 | 398,121,000 | 346,888,000 | 278,193 | 485,081 |
| property and equipment | 177,880,000 | 165,775,000 | 167,947,000 | 157,680,000 | 151,024,000 | 159,164,000 | 166,471,000 | 136,713,000 | 118,257,000 | 102,275,000 | 103,868,000 | 103,991,000 | 90,932,000 | 83,102,000 | 76,613,000 | 61,596,000 | ||
| customer relationship intangibles and other intangibles | 34,015,000 | 35,205,000 | 36,394,000 | 37,583,000 | 38,774,000 | 39,963,000 | 42,168,000 | |||||||||||
| operating lease, right-of-use assets | 12,353,000 | 12,921,000 | 13,479,000 | 13,810,000 | 14,333,000 | 14,851,000 | 15,290,000 | 5,912,000 | 6,059,000 | 6,205,000 | 6,133,000 | 6,270,000 | 6,407,000 | 6,535,000 | 6,669,000 | 6,796,000 | ||
| goodwill | 12,217,000 | 12,217,000 | 12,217,000 | 12,217,000 | 12,217,000 | 12,217,000 | 12,098,000 | |||||||||||
| other assets, non-current | 4,307,000 | 2,755,000 | 2,126,000 | 2,746,000 | 2,691,000 | 4,700,000 | 5,100,000 | 780,000 | 825,000 | 881,000 | 937,000 | 1,787,000 | 1,049,000 | 1,105,000 | 1,162,000 | 141,000 | ||
| total assets | 469,112,000 | 499,045,000 | 527,169,000 | 448,021,000 | 488,988,000 | 508,903,000 | 564,304,000 | 519,942,000 | 538,955,000 | 410,605,000 | 440,586,000 | 467,559,000 | 487,255,000 | 506,291,000 | 482,565,000 | 415,421,000 | 230,289,640 | 230,501,182 |
| liabilities and stockholders’ equity | ||||||||||||||||||
| current liabilities: | ||||||||||||||||||
| accounts payable | 13,906,000 | 20,610,000 | 9,492,000 | 15,046,000 | 19,431,000 | 19,277,000 | 21,251,000 | 18,272,000 | 13,341,000 | 4,751,000 | 7,077,000 | 6,816,000 | 6,133,000 | 1,535,000 | 3,144,000 | 1,713,000 | ||
| accrued expenses | 6,216,000 | 8,540,000 | 19,843,000 | 13,855,000 | 16,530,000 | 11,677,000 | 13,976,000 | 15,784,000 | 12,634,000 | 8,685,000 | 7,089,000 | 2,476,000 | 3,357,000 | 4,620,000 | 7,109,000 | 4,520,000 | 187,708 | |
| accrued compensation | 8,301,000 | 6,481,000 | 8,228,000 | 8,038,000 | 8,856,000 | 9,281,000 | 10,731,000 | 9,126,000 | 10,116,000 | 10,400,000 | 8,097,000 | 6,169,000 | 6,579,000 | 4,850,000 | 4,101,000 | 3,107,000 | ||
| short-term debt | 10,407,000 | 10,367,000 | 9,452,000 | 11,555,000 | 10,989,000 | 8,488,000 | 5,917,000 | |||||||||||
| deferred revenue | 8,074,000 | 6,630,000 | 3,650,000 | 6,206,000 | 7,007,000 | 5,306,000 | 6,708,000 | 350,000 | 350,000 | 50,000 | 1,373,000 | 275,000 | 5,575,000 | 5,575,000 | 5,495,000 | |||
| other liabilities | 5,371,000 | 5,161,000 | 3,036,000 | 4,760,000 | 5,090,000 | 2,855,000 | 2,435,000 | 944,000 | 942,000 | 916,000 | 716,000 | 695,000 | 722,000 | 875,000 | 707,000 | 660,000 | ||
| total current liabilities | 52,275,000 | 57,789,000 | 53,701,000 | 59,460,000 | 67,903,000 | 56,884,000 | 61,018,000 | 44,126,000 | 37,383,000 | 25,102,000 | 23,029,000 | 17,529,000 | 17,066,000 | 17,455,000 | 20,636,000 | 15,495,000 | 196,790,205 | 78,862,708 |
| long-term debt | 169,441,000 | 169,185,000 | 169,820,000 | 168,744,000 | 168,500,000 | 168,275,000 | 169,099,000 | 167,080,000 | 166,805,000 | |||||||||
| warrant liability | 18,469,000 | 12,584,000 | 28,380,000 | 23,265,000 | 55,440,000 | 21,780,000 | 42,900,000 | 44,940,000 | 76,260,000 | 61,920,000 | 49,080,000 | 80,220,000 | 30,060,000 | 56,460,000 | 124,260,000 | 64,440,000 | 188,110,000 | 70,625,000 |
| operating lease liabilities, non-current | 12,182,000 | 12,638,000 | 13,293,000 | 14,346,000 | 14,182,000 | 14,813,000 | 15,594,000 | 7,538,000 | 7,775,000 | 8,010,000 | 8,234,000 | 8,449,000 | 8,661,000 | 8,870,000 | 9,071,000 | 9,263,000 | ||
| deferred revenue, non-current | 300,000 | 300,000 | 3,774,000 | 3,774,000 | 3,774,000 | 3,774,000 | 3,774,000 | 3,774,000 | 3,424,000 | 3,424,000 | 3,724,000 | 2,964,000 | 2,590,000 | 2,290,000 | 2,290,000 | 2,290,000 | ||
| deferred tax liability | 9,778,000 | 8,751,000 | 8,784,000 | 8,178,000 | 6,115,000 | 11,259,000 | 10,803,000 | |||||||||||
| other liabilities, non-current | 15,000 | 14,000 | 14,000 | 12,000 | 11,000 | 13,000 | 13,000 | 9,000 | 24,000 | 38,000 | 92,000 | 114,000 | 138,000 | 162,000 | 191,000 | 227,000 | ||
| total liabilities | 262,460,000 | 261,261,000 | 277,766,000 | 277,779,000 | 315,925,000 | 276,798,000 | 303,201,000 | 267,467,000 | 291,671,000 | 98,494,000 | 84,159,000 | 109,276,000 | 58,515,000 | 85,237,000 | 156,448,000 | 91,715,000 | 196,790,205 | |
| commitments and contingencies | ||||||||||||||||||
| stockholders’ equity: | ||||||||||||||||||
| common stock | 19,000 | 19,000 | 19,000 | 18,000 | 18,000 | 17,000 | 17,000 | 16,000 | 16,000 | 16,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 14,000 | 2,590 | 1,409 |
| additional paid-in-capital | 1,093,245,000 | 1,079,904,000 | 1,067,951,000 | 951,237,000 | 931,363,000 | 874,527,000 | 857,037,000 | 791,340,000 | 769,975,000 | 770,472,000 | 741,186,000 | 731,861,000 | 720,305,000 | 711,484,000 | 659,254,000 | 572,276,000 | ||
| accumulated other comprehensive loss | -391,000 | -184,000 | -143,000 | -42,000 | -53,000 | -62,000 | -13,000 | -24,000 | ||||||||||
| accumulated deficit | -889,124,000 | -844,596,000 | -821,086,000 | -783,621,000 | -761,085,000 | -645,213,000 | -598,845,000 | -538,868,000 | -522,683,000 | -458,377,000 | -384,774,000 | -373,593,000 | -291,580,000 | -290,445,000 | -333,152,000 | -248,584,000 | -171,985,670 | -53,846,631 |
| total enovix stockholders’ equity | 203,749,000 | 235,143,000 | ||||||||||||||||
| non-controlling interest | 2,903,000 | 2,641,000 | 2,662,000 | 2,650,000 | 2,752,000 | 2,827,000 | 2,956,000 | |||||||||||
| total equity | 206,652,000 | 237,784,000 | 249,403,000 | 170,242,000 | 173,063,000 | 232,105,000 | 261,103,000 | |||||||||||
| total liabilities and equity | 469,112,000 | 499,045,000 | 527,169,000 | 448,021,000 | 488,988,000 | 508,903,000 | 564,304,000 | |||||||||||
| preferred stock, 0.0001 par value; authorized shares of 10,000,000; no shares issued or outstanding as of december 29, 2024 and december 31, 2023, respectively | ||||||||||||||||||
| total enovix's stockholders’ equity | 246,741,000 | 167,592,000 | 170,311,000 | 229,278,000 | 258,147,000 | |||||||||||||
| accumulated other comprehensive gain | 15,000 | |||||||||||||||||
| preferred stock, 0.0001 par value; authorized shares of 10,000,000; no shares issued or outstanding as of december 31, 2023 and january 1, 2023, respectively | ||||||||||||||||||
| deferred contract costs | 800,000 | 800,000 | 800,000 | 1,539,000 | 1,340,000 | 4,547,000 | 4,554,000 | 4,371,000 | ||||||||||
| deferred contract costs, non-current | 800,000 | |||||||||||||||||
| preferred stock, 0.0001 par value; authorized shares of 10,000,000; no shares issued or outstanding as of october 1, 2023 and january 1, 2023, respectively | ||||||||||||||||||
| total stockholders’ equity | 252,475,000 | 247,284,000 | 312,111,000 | 356,427,000 | 358,283,000 | 428,740,000 | 421,054,000 | 326,117,000 | 323,706,000 | |||||||||
| total liabilities and stockholders’ equity | 519,942,000 | 538,955,000 | 410,605,000 | 440,586,000 | 467,559,000 | 487,255,000 | 506,291,000 | |||||||||||
| preferred stock, 0.0001 par value; authorized shares of 10,000,000; no shares issued or outstanding as of july 2, 2023 and january 1, 2023, respectively | ||||||||||||||||||
| preferred stock, 0.0001 par value; authorized shares of 10,000,000; no shares issued or outstanding as of april 2, 2023 and january 1, 2023, respectively | ||||||||||||||||||
| preferred stock, 0.0001 par value; authorized shares of 10,000,000; no shares issued or outstanding as of january 1, 2023 and january 2, 2022, respectively | ||||||||||||||||||
| preferred stock, 0.0001 par value; authorized shares of 10,000,000; no shares issued or outstanding as of october 2, 2022 and january 2, 2022, respectively | ||||||||||||||||||
| preferred stock, 0.0001 par value; authorized shares of 10,000,000; no shares issued or outstanding as of july 3, 2022 and january 2, 2022, respectively | ||||||||||||||||||
| preferred stock, 0.0001 par value; authorized shares of 10,000,000; no shares issued or outstanding as of april 3, 2022 and january 2, 2022, respectively | ||||||||||||||||||
| liabilities, convertible preferred stock and stockholders’ equity | ||||||||||||||||||
| deferred rent, non-current | ||||||||||||||||||
| preferred stock, 0.0001 par value; authorized shares of 10,000,000 and none as of january 2, 2022 and december 31, 2020; none issued and outstanding shares as of january 2, 2022 and december 31, 2020, respectively | ||||||||||||||||||
| total liabilities, convertible preferred stock and stockholders’ equity | 482,565,000 | 415,421,000 | ||||||||||||||||
| preferred stock, 0.0001 par value; authorized shares of 10,000,000 and 0 as of october 3, 2021 and december 31, 2020; none issued and outstanding shares as of october 3, 2021 and december 31, 2020, respectively | ||||||||||||||||||
| current assets | ||||||||||||||||||
| cash | 142,943 | 305,093 | ||||||||||||||||
| prepaid expenses | 135,250 | 179,988 | ||||||||||||||||
| cash held in trust account | 230,011,447 | |||||||||||||||||
| liabilities and stockholders' equity | ||||||||||||||||||
| current liabilities | ||||||||||||||||||
| accounts payable and accrued expenses | 630,205 | |||||||||||||||||
| deferred underwriting fee payable | 8,050,000 | 8,050,000 | ||||||||||||||||
| common stock subject to possible redemption; 2,849,943 shares at redemption value | 28,499,426 | |||||||||||||||||
| stockholders' equity | ||||||||||||||||||
| preferred stock, 0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding | ||||||||||||||||||
| additional paid in capital | 176,983,089 | 58,845,226 | ||||||||||||||||
| total stockholders' equity | 5,000,009 | 5,000,004 | ||||||||||||||||
| total liabilities and stockholders' equity | 230,289,640 | 230,501,182 | ||||||||||||||||
| cash and securities held in trust account | 230,016,101 | |||||||||||||||||
| common stock subject to possible redemption; 14,663,874 shares at redemption value | 146,638,470 | |||||||||||||||||
| preferred stock, 0.0001 par value; 1,000,000 shares authorized |
We provide you with 20 years of balance sheets for Enovix stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Enovix. Explore the full financial landscape of Enovix stock with our expertly curated balance sheets.
The information provided in this report about Enovix stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.